Search

Dale R. Miller

Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1673, 1693
Total Applications
838
Issued Applications
502
Pending Applications
84
Abandoned Applications
276

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17836387 [patent_doc_number] => 20220273692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => THERAPEUTIC AGENT FOR NERVOUS SYSTEM DISEASE [patent_app_type] => utility [patent_app_number] => 17/748553 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748553 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748553
Therapeutic agent for nervous system disease May 18, 2022 Issued
Array ( [id] => 19556412 [patent_doc_number] => 20240368204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/560481 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560481 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/560481
SMALL MOLECULAR CD73 ANTAGONIST AND USE THEREOF May 9, 2022 Pending
Array ( [id] => 19345509 [patent_doc_number] => 20240254472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => COMPOSITIONS AND METHODS FOR SIMPLE SAMPLE EXTRACTION [patent_app_type] => utility [patent_app_number] => 18/289431 [patent_app_country] => US [patent_app_date] => 2022-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17904 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289431 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/289431
COMPOSITIONS AND METHODS FOR SIMPLE SAMPLE EXTRACTION May 4, 2022 Pending
Array ( [id] => 19263608 [patent_doc_number] => 20240207305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => USE OF CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN [patent_app_type] => utility [patent_app_number] => 18/555982 [patent_app_country] => US [patent_app_date] => 2022-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/555982
Use of chondroitin sulfate for relieving ocular pain Apr 30, 2022 Issued
Array ( [id] => 20015965 [patent_doc_number] => 20250154187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-15 [patent_title] => COMPOSITIONS AND METHODS RELATED TO MODIFICATION AND DETECTION OF PSEUDOURIDINE AND 5-HYDROXYMETHYLCYTOSINE [patent_app_type] => utility [patent_app_number] => 18/556842 [patent_app_country] => US [patent_app_date] => 2022-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556842 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/556842
COMPOSITIONS AND METHODS RELATED TO MODIFICATION AND DETECTION OF PSEUDOURIDINE AND 5-HYDROXYMETHYLCYTOSINE Apr 26, 2022 Pending
Array ( [id] => 20577274 [patent_doc_number] => 12569509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Method and composition for preventing and treating viral infections [patent_app_type] => utility [patent_app_number] => 17/729711 [patent_app_country] => US [patent_app_date] => 2022-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 72 [patent_no_of_words] => 12032 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729711 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/729711
Method and composition for preventing and treating viral infections Apr 25, 2022 Issued
Array ( [id] => 20207486 [patent_doc_number] => 20250277206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-09-04 [patent_title] => METHOD FOR EXTRACTING NUCLEIC ACID FROM SAMPLE RICH IN POLYPHENOL AND/OR POLYSACCHARIDE [patent_app_type] => utility [patent_app_number] => 18/550970 [patent_app_country] => US [patent_app_date] => 2022-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550970 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/550970
METHOD FOR EXTRACTING NUCLEIC ACID FROM SAMPLE RICH IN POLYPHENOL AND/OR POLYSACCHARIDE Apr 18, 2022 Pending
Array ( [id] => 19187767 [patent_doc_number] => 20240166680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => NUCLEOSIDE ANALOG AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/286416 [patent_app_country] => US [patent_app_date] => 2022-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13949 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 434 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286416 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/286416
NUCLEOSIDE ANALOG AND USE THEREOF Apr 11, 2022 Pending
Array ( [id] => 19140442 [patent_doc_number] => 20240139226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => A COMPOSITION FOR PROMOTING GLP-1 SECRETION [patent_app_type] => utility [patent_app_number] => 18/553882 [patent_app_country] => US [patent_app_date] => 2022-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553882 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553882
A COMPOSITION FOR PROMOTING GLP-1 SECRETION Mar 29, 2022 Pending
Array ( [id] => 18483578 [patent_doc_number] => 20230210876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING PENTACYCLIC TRITERPENOIDS [patent_app_type] => utility [patent_app_number] => 17/923776 [patent_app_country] => US [patent_app_date] => 2022-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923776 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923776
Pharmaceutical composition containing pentacyclic triterpenoids Mar 24, 2022 Issued
Array ( [id] => 19156071 [patent_doc_number] => 20240148778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => GLYCOSIDE INHIBITORS OF YEAST [patent_app_type] => utility [patent_app_number] => 18/550349 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550349 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/550349
GLYCOSIDE INHIBITORS OF YEAST Mar 14, 2022 Pending
Array ( [id] => 19832332 [patent_doc_number] => 20250084118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => NOVEL DEALKOXYPHENYLATION REACTION [patent_app_type] => utility [patent_app_number] => 18/549797 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549797 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549797
NOVEL DEALKOXYPHENYLATION REACTION Mar 10, 2022 Pending
Array ( [id] => 19389494 [patent_doc_number] => 20240279364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => GLYCAN, AND METHOD FOR PRODUCING MEDICINE CONTAINING GLYCAN [patent_app_type] => utility [patent_app_number] => 18/549949 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549949 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549949
GLYCAN, AND METHOD FOR PRODUCING MEDICINE CONTAINING GLYCAN Mar 10, 2022 Pending
Array ( [id] => 19075295 [patent_doc_number] => 11944638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-02 [patent_title] => Ophthalmic solutions [patent_app_type] => utility [patent_app_number] => 17/691265 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3985 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691265 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691265
Ophthalmic solutions Mar 9, 2022 Issued
Array ( [id] => 19187771 [patent_doc_number] => 20240166684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => COMPOUNDS FOR ALTERING LEVELS OF ONE OR MORE NKA ALPHA SUBUNITS AND THEIR USE IN TREATING PRION DISEASES OR BRAIN DISEASES ASSOCIATED WITH CELLULAR PRION PROTEIN [patent_app_type] => utility [patent_app_number] => 18/280977 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280977 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/280977
COMPOUNDS FOR ALTERING LEVELS OF ONE OR MORE NKA ALPHA SUBUNITS AND THEIR USE IN TREATING PRION DISEASES OR BRAIN DISEASES ASSOCIATED WITH CELLULAR PRION PROTEIN Mar 9, 2022 Pending
Array ( [id] => 19157682 [patent_doc_number] => 20240150389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => MODIFIED GUANINES [patent_app_type] => utility [patent_app_number] => 18/277642 [patent_app_country] => US [patent_app_date] => 2022-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277642 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277642
Modified guanines Feb 20, 2022 Issued
Array ( [id] => 20116078 [patent_doc_number] => 12365768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-22 [patent_title] => Method for deacetylation of biopolymers [patent_app_type] => utility [patent_app_number] => 17/676675 [patent_app_country] => US [patent_app_date] => 2022-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10758 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/676675
Method for deacetylation of biopolymers Feb 20, 2022 Issued
Array ( [id] => 18043645 [patent_doc_number] => 11517578 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-12-06 [patent_title] => Topical formulations containing erythritol and methods of treating skin conditions [patent_app_type] => utility [patent_app_number] => 17/673532 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16340 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673532 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/673532
Topical formulations containing erythritol and methods of treating skin conditions Feb 15, 2022 Issued
Array ( [id] => 20385424 [patent_doc_number] => 12485133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-02 [patent_title] => Inhaled ivermectin [patent_app_type] => utility [patent_app_number] => 17/592691 [patent_app_country] => US [patent_app_date] => 2022-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3812 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/592691
Inhaled ivermectin Feb 3, 2022 Issued
Array ( [id] => 18683851 [patent_doc_number] => 11779561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => Compounds and pharmaceutical uses thereof [patent_app_type] => utility [patent_app_number] => 17/590771 [patent_app_country] => US [patent_app_date] => 2022-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 35417 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590771 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/590771
Compounds and pharmaceutical uses thereof Jan 31, 2022 Issued
Menu